Sheri Gibson, in Artesia, MS - Occupational Therapist

Sheri Gibson, is a Occupational Therapist based in Artesia, Mississippi. Sheri Gibson is licensed to practice in Mississippi (license number OT1968) and her current practice location is 2165 Schlater Rd., Artesia, Mississippi. She can be reached at her office (for appointments etc.) via phone at (601) 248-0080.

NPI number for Sheri Gibson is 1912486606 and her current mailing address is Po Box 7, Artesia, Mississippi. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1912486606.

Contact Information

	Sheri Gibson,
	2165 Schlater Rd., Artesia, MS 39736-3973
	(601) 248-0080
	Not Available

Healthcare Provider's Profile

Full Name	Sheri Gibson
Gender	Female
Speciality	Occupational Therapist
Location	2165 Schlater Rd., Artesia, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1912486606
Provider Enumeration Date: 08/13/2018
Last Update Date: 08/13/2018

Medical Identifiers

Medical identifiers for Sheri Gibson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912486606	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	OT1968 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sheri Gibson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sheri Gibson, Po Box 7, Artesia, MS 39736-0007 Ph: (601) 248-0080	Sheri Gibson, 2165 Schlater Rd., Artesia, MS 39736-3973 Ph: (601) 248-0080

News Archive

Challenges related to premarket clearance process for medical devices: FDA schedules public meeting

The U.S. Food and Drug Administration announced today that it has scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States. The FDA receives more than 3,000 510(k) submissions each year.

Metiscan closes equity funding of $7.3M

Metiscan, Inc. (PINKSHEETS: MTIZ), a holding company focused on growing its organization by making key acquisitions and developing companies and emerging technologies, announced today that it has closed an equity funding of $7.3M, which has been deposited in a restricted cash account owned by Metiscan. Funds shall be distributed subject to a registration statement filed with the SEC becoming effective and other conditions outlined in an account management agreement. The investors also have the option to exercise warrants up to $10M.

Yoga offers unique benefits for women with breast cancer undergoing radiation therapy

For women with breast cancer undergoing radiation therapy, yoga offers unique benefits beyond fighting fatigue, according to research from The University of Texas MD Anderson Cancer Center.

Botulinum toxin effective in treating OAB among women

The biggest study into the treatment of urinary incontinence with botulinum toxin (trade name Botox) has demonstrated that it is effective in treating overactive bladder (OAB) - a debilitating common condition which can affect up to 20% of people over the age of 40.

Sheri Gibson, - Occupational Therapist in Artesia, MS